Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria.

Abstract

To test the efficacy of tyrosine supplementation, as an adjunct to dietary treatment, on neuropsychological test performance in individuals with phenylketonuria. A randomised controlled trial of tyrosine supplementation using a double blind crossover procedure with three four week phases. The Hospital for Sick Children, Toronto. 21 individuals with phenylketonuria (ages 6 to 28 years, mean 11.3). Participants were given 100 mg/kg body weight/d of L-tyrosine or L-alanine (placebo). At baseline, performance on several of the neuropsychological test measures was correlated with tyrosine levels. Dietary supplements of tyrosine increased plasma tyrosine concentrations; however, no change in test performance was found across the tyrosine and placebo phases of the study. Tyrosine supplementation of this type does not appear to alter neuropsychological performance in individuals with phenylketonuria.